Leonard Shanon J 4
4 · TEXAS INSTRUMENTS INC · Filed Apr 27, 2026
Research Summary
AI-generated summary of this filing
Texas Instruments Sr. VP Leonard Shanon Exercises Options, Sells 18,189
What Happened
- Leonard Shanon, Senior Vice President at Texas Instruments (TXN), exercised option awards and sold the resulting 18,189 shares on April 24, 2026.
- He exercised four option tranches (1,700; 3,423; 5,529; 7,537 shares) paying a total exercise cost of $2,877,483, and sold all 18,189 shares in the open market for total proceeds of $5,055,707 (weighted avg sale price $277.95). Net proceeds (proceeds minus exercise cost) ≈ $2,178,224.
- The filing shows the options were converted (reported as disposals of the derivative at $0.00) and the underlying shares were sold the same day.
Key Details
- Transaction date: 2026-04-24; Form 4 filed 2026-04-27 (timely).
- Sale details: 18,189 shares sold at a weighted-average price of $277.95; reported sale prices ranged from $277.36 to $278.30 (footnote F1).
- Exercises: four option exercises with exercise prices and amounts:
- 1,700 shares @ $104.41 = $177,497
- 3,423 shares @ $130.52 = $446,770
- 5,529 shares @ $169.23 = $935,673
- 7,537 shares @ $174.81 = $1,317,543
- Aggregate: 18,189 shares acquired via exercise (total exercise cost $2,877,483) and immediately sold for $5,055,707.
- Shares owned after transaction: not disclosed in the provided filing excerpt.
- Notable footnotes:
- F1: sale price range and weighted-average note; detailed breakdown available on request.
- F2–F5: the option tranches became exercisable in four equal annual installments beginning in 2020, 2021, 2022 and 2023, respectively (indicating vested/long-standing grants).
Context
- This pattern — exercising vested options and selling the resulting shares the same day — is commonly a cashless exercise/liquidity event (options converted to shares and sold immediately). The filing shows both the option conversion (derivative reported as disposed) and the open-market sale.
- The transaction is factual disclosure of insider activity and does not, by itself, indicate the insider’s view on the company’s future prospects.
Insider Transaction Report
Form 4
Leonard Shanon J
Sr. Vice President
Transactions
- Exercise/Conversion
Common Stock
2026-04-24$104.41/sh+1,700$177,497→ 33,675 total - Exercise/Conversion
Common Stock
2026-04-24$130.52/sh+3,423$446,770→ 37,098 total - Exercise/Conversion
Common Stock
2026-04-24$169.23/sh+5,529$935,673→ 42,627 total - Exercise/Conversion
Common Stock
2026-04-24$174.81/sh+7,537$1,317,543→ 50,164 total - Sale
Common Stock
[F1]2026-04-24$277.95/sh−18,189$5,055,707→ 31,975 total - Exercise/Conversion
NQ Stock Option (Right to Buy)
[F2]2026-04-24−1,700→ 0 totalExercise: $104.41Exp: 2029-01-25→ Common Stock (1,700 underlying) - Exercise/Conversion
NQ Stock Option (Right to Buy)
[F3]2026-04-24−3,423→ 0 totalExercise: $130.52Exp: 2030-01-24→ Common Stock (3,423 underlying) - Exercise/Conversion
NQ Stock Option (Right to Buy)
[F4]2026-04-24−5,529→ 0 totalExercise: $169.23Exp: 2031-01-28→ Common Stock (5,529 underlying) - Exercise/Conversion
NQ Stock Option (Right to Buy)
[F5]2026-04-24−7,537→ 0 totalExercise: $174.81Exp: 2032-01-27→ Common Stock (7,537 underlying)
Footnotes (5)
- [F1]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $277.36 to $278.3. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
- [F2]The option became exercisable in four equal annual installments beginning on January 25, 2020.
- [F3]The option became exercisable in four equal annual installments beginning on January 24, 2021.
- [F4]The option became exercisable in four equal annual installments beginning on January 28, 2022.
- [F5]The option became exercisable in four equal annual installments beginning on January 27, 2023.
Signature
/s/ Shannon Thompson, Attorney in Fact|2026-04-27